Irish industry’s chief looks for partnership as he admits trust is lacking
Ex-chief of innovative health unit Bourla to assume control as Read becomes executive chairman
Sales slip for third quarter in a row as leading drug group misses analyst projections
Pharma giant facing into expiry of key patents and investors are becoming itchy
Pharma giant increase US price of nearly 100 medicines by average of 20 per cent this year
Company’s shares down 1.3% in premarket trading after it says it will not separate
Several hundred jobs likely to be created at former Wyeth facility in west Dublin
Impact on share prices of uncertainty over UK’s EU future difficult to calculate
Ian Read says rules to stop inversions will create ‘permanent advantage’ for rivals
Except for the firms involved, few in the US or Ireland benefit from inversion deals
Activist investor Carl Icahn argues that deal will open the floodgates for other companies to leave the US
Deal makes Ireland home to the largest pharmaceutical company in the world
Democrats call for US tax reform after Pfizer, Allergan agree $160bn Irish-based merger
Pfizer $160bn purchase of Allergan will see firm move HQ to Dublin
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices